LC/MS and GC/MS Analysis of Potential Genotoxic Impurities in Active Pharmaceutical Ingredients

Guidelines have recently been established for levels of potential genotoxic impurities (PGIs) in pharmaceutical APIs. This webinar outlines LC/MS and GC/MS methods developed in collaboration with Merck & Co.

Narrated by Amanda Rigdon, Innovations Chemist. Length: 17 minutes
You need to be logged in to view this content. If you don't have an account at, click here to register.